AML with MDS-related changes and blasts of mixed lineage: time for a new provisional entity?

  • Matthew M. Klairmont, Jinjun Cheng, Joel F. Gradowski
  • Leukemia & Lymphoma, April 2018, Taylor & Francis
  • DOI: 10.1080/10428194.2018.1443451

The authors haven't yet claimed this publication.

Read Publication

http://dx.doi.org/10.1080/10428194.2018.1443451